NMN vs NR Supplements Ranked: What Testing and Human Trials Actually Show
Independent lab testing found most NMN products on Amazon contain no detectable ingredient. Here's what the evidence says about which NAD+ supplements actually work.
Summary
NAD+ precursor supplements — NR and NMN — are among the most popular longevity products on the market, but independent quality testing reveals a troubling reality: ConsumerLab found 14 of 22 popular NMN supplements on Amazon contained no detectable NMN, and only 26 of 70 NR products met label claims. Expert reviews and a 2025 head-to-head human study show both NR and NMN can raise whole-blood NAD+ levels, with NR having the stronger published safety and replication record. Among reviewed products, Tru Niagen (NR) ranks highest for evidence quality and quality control, while PartiQlar Pure NMN leads budget NMN options. Buyers are advised to prioritize third-party tested products with a Certificate of Analysis and avoid unverified marketplace offerings given the high product failure rate.
Detailed Summary
NAD+ decline is one of the most consistently documented features of biological aging, making NAD+ precursor supplementation a major focus for longevity-oriented consumers and clinicians alike. But the supplement market for these compounds has a serious quality problem that makes product selection far more consequential than it might appear.
This expert review and product roundup synthesizes current evidence on nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) supplements, combining published human study data with independent laboratory quality testing. The analysis evaluated six major products across price points and formula types, rating each on evidence quality, third-party certification status, and cost per serving.
The headline finding is that product quality failures are widespread. ConsumerLab testing found that 14 of 22 popular NMN supplements on Amazon contained no detectable NMN whatsoever, while only 26 of 70 NR products came close to their label claims. These failure rates underscore that brand selection and third-party verification are not optional for this supplement category. A 2025 head-to-head human study confirmed that both NR and NMN raise whole-blood NAD+ levels, and that the difference between them is smaller than most marketing suggests. NR maintains the stronger overall safety and replication record across human studies, while NMN shows promise for specific tissue targets and functional endpoints, though those advantages remain less firmly established.
Among reviewed products, Tru Niagen leads for evidence quality and consistency, PartiQlar Pure NMN offers the strongest budget NMN option, and Omre NMN plus Resveratrol is a reasonable premium combination choice. The review recommends against purchasing unverified NMN or NR products without a Certificate of Analysis given the documented contamination and mislabeling rates.
The practical implication for clinicians and informed consumers is clear: supplement selection in this category requires active quality verification, not just brand recognition or price comparison.
Key Findings
- 14 of 22 popular NMN supplements on Amazon had no detectable NMN in independent ConsumerLab testing.
- Only 26 of 70 NR supplements tested met label potency claims; many contained little to none.
- A 2025 human study confirmed both NR and NMN raise whole-blood NAD+; the difference between them is smaller than marketed.
- NR (Tru Niagen) holds the stronger published human safety and replication record among NAD+ precursors.
- Always require a Certificate of Analysis and third-party potency testing before purchasing any NAD+ supplement.
Methodology
This is a product review and expert roundup article published by Forbes Health, synthesizing independent laboratory quality testing data from ConsumerLab, published human clinical studies including a 2025 head-to-head NR vs. NMN trial, and expert commentary. It is not a peer-reviewed systematic review or meta-analysis. Findings reflect a curated narrative review of available consumer and scientific sources.
Study Limitations
This summary is based on a product review article, not a peer-reviewed academic paper; conclusions reflect editorial synthesis rather than primary research. ConsumerLab testing data are not publicly detailed in this summary, limiting assessment of methodology. The review does not address individual variation in NAD+ response, optimal dosing, or long-term clinical outcomes.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
